These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5585478)

  • 1. [Results with cyclophosphamide therapy in single and massive dosage].
    Helbig W; Mühl H
    Z Gesamte Inn Med; 1967 Dec; 22(24):811-4. PubMed ID: 5585478
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with high dosage cytostatic "high single dose" therapy of malignant tumors].
    Zerna M; Wolff H
    Bruns Beitr Klin Chir (1971); 1966 Mar; 212(2):146-53. PubMed ID: 5994826
    [No Abstract]   [Full Text] [Related]  

  • 3. [Limits and possibilities of cytostatic therapy with massive doses of cyclophosphamide].
    Chiarelli G; Garutti GP; Rambaldi P
    Arcisp S Anna Ferrara; 1967; 20(3):385-400. PubMed ID: 5606860
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of intraoperative massive dose therapy on the postoperative condition].
    Schmidt D
    Wien Med Wochenschr; 1969 Jan; 119(1):15-8. PubMed ID: 5773406
    [No Abstract]   [Full Text] [Related]  

  • 5. [First clinical experiences with ultrahigh single doses of cyclophosphamide].
    Schmitz G; Gross R
    Med Welt; 1967 Apr; 16():985-9. PubMed ID: 5585096
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapy.
    Lee WJ; Zimmerman T; Meyers S; Bender JG; Williams SF
    Prog Clin Biol Res; 1994; 389():421-7. PubMed ID: 7535451
    [No Abstract]   [Full Text] [Related]  

  • 7. [Middle-high dose of cyclophosphamide or conventional routine chemotherapy with increased dose of cyclophosphamide combined with G-CSF for mobilizing peripheral blood progenitor cells in patients with tumor].
    Lu DP; Liu KY; Guo NL; Shi YK; He XH; Lou FD; Da WM; Zhang BL; Wang LX; Ke XY
    Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):68-70. PubMed ID: 12697098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cyclophosphamide in high dosage forms as gynecologic neoplasm therapy].
    Tukiainen P
    Duodecim; 1968; 84(12):763-73. PubMed ID: 5685562
    [No Abstract]   [Full Text] [Related]  

  • 9. [Autologous stem cell harvesting after high dosage chemo- and/or growth factor therapy].
    Kasparu H; Krieger O; Bettelheim P; Kolb A; Lutz D
    Wien Med Wochenschr; 1995; 145(2-3):58-60. PubMed ID: 7539197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the problem of intraoperative cytostatic high dosage therapy in the treatment of cancer. I].
    Kirsch R; Schmidt D; Fichler J
    Zentralbl Chir; 1967 Sep; 92(38):2559-70 contd. PubMed ID: 5595511
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.
    Bergsagel DE; Robertson GL; Hasselback R
    Can Med Assoc J; 1968 Mar; 98(11):532-8. PubMed ID: 5643297
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the problem of intraoperative cytostatic massive-dose therapy in the management of carcinoma. II].
    Kirsch R; Schmidt D; Fichler J
    Zentralbl Chir; 1967 Sep; 92(39):2595-607 concl. PubMed ID: 5586585
    [No Abstract]   [Full Text] [Related]  

  • 13. [Compatibility and action of very high dosage of endoxuan in the treatment of tumors].
    Martini H; Scheef W; Knecht B
    Med Welt; 1967 Jul; 26():1573-8. PubMed ID: 5616188
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results obtained by high doses of cyclophosphamide in solid tumors].
    Bilge N; Aran M
    Turk Tip Cemiy Mecm; 1970 Feb; 36(2):116-27. PubMed ID: 5502530
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with the endoxan intensive therapy of malignant tumors].
    Gebhardt KH; Becher R
    Med Welt; 1966 Apr; 17():973-6. PubMed ID: 5985776
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
    Mahendra P; Johnson D; Scott MA; Jestice HK; Hood IM; Ager S; Bass G; Barker P; Boraks PA; Bloxham DM; Baglin TP; Marcus RE
    Bone Marrow Transplant; 1996 Apr; 17(4):503-7. PubMed ID: 8722346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of disulfiram on cyclophosphamide toxicity: a clinical trial.
    Ershler WB; Hacker MP; Newman RA; Stewart JA; Gamelli RL; Krakoff IH
    Cancer Treat Rep; 1983 Dec; 67(12):1145-7. PubMed ID: 6652633
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I trials of WR2721 in combination with radiation therapy and with the alkylating agents cyclophosphamide and cis-platinum.
    Kligerman MM; Blumberg AL; Glick JH; Nelson DF; Glover D; Yuhas JM; Amols HI; Goodman RL
    Cancer Clin Trials; 1981; 4(4):469-74. PubMed ID: 6274534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term postoperative treatment with cyclophosphamide].
    Wilmanns H
    Laval Med; 1968 Oct; 39(8):728-33. PubMed ID: 5748238
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems of clinical cancerology: cytostatic shock with cyclophosphamide].
    Cittadini G
    Minerva Med; 1966 May; 57(39):1715-23. PubMed ID: 5939618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.